Multiple Myeloma: Diagnosis and survival
CR Magazine: Collaberation – Results

Back to the Main Article

Dear Ann Landers

Millions of readers turned to columnist Ann Landers for advice on relationships, work and even cancer research, until her death from multiple myeloma in 2002.

For More Information


We've provided resources for you to find more information about the stories in this issue.



Multiple Myeloma: Diagnosis and survival

The International Staging System categorizes multiple myeloma into three stages based on the results of blood concentrations of two proteins: beta-2 microglobulin (ß2-M), a protein that indicates the extent of the disease, and albumin, a protein that is an indicator of overall health.

Stage I
Serum ß2-M less than 3.5 mg/L and a serum albumin less than 3.5 g/dL.
Median survival of 62 months.

Stage II
Defined as not being stage I or III.
Median survival of 44 months.

Stage III
Serum ß2-M of at least 5.5 mg/L.
Median survival of 29 months.